Astellas has confirmed that it will make an upfront cash payment of $80 million to CytomX.
News
Novavax plans FDA filing after NanoFlu trumps Sanofi flu vaccine
The vaccine met all primary endpoints in adults aged 65 and older against Sanofi’s Fluzone Quadrivalent.
Botox gets license update in UK
Previously the licence referred to “physicians”, prompting confusion over who is able to inject the treatment.
Bayer enlists Curadev in STING antagonist collaboration
STING is known to play a role in activating the innate immune system in auto-inflammatory diseases.
Hep C cases down around 70% in HIV positive men in London and Brighton
Regular hepatitis C screening and improved access to new treatments has potentially contributed to greatly reducing the transmission of the infection.
COVID-19: AstraZeneca to distribute masks as ASCO goes virtual
PHE has also been awarded $500,000 by the US FDA to bolster the international response.
AZ to develop siRNA with Silence Theraputics
siRNA are double-stranded RNA molecules that offer new opportunities for therapeutic intervention because they act inside the cell to influence protein production.
Venclexta/Venclyxto combo extends myeloid leukaemia survival
Roche also reported that safety for Venclexta/Venclyxto with azacitidine appeared consistent with the known safety profile of these medicines.
COVID-19: Gilead deals with ‘overwhelming’ remdesivir demands, Eli Lilly halts trial enrolment
The current recorded case count for COVID-19 (coronavirus) in the UK has hit 6,650, with 335 deaths and 135 recoveries.
COVID-19: NIHR awards £10.5m to six new projects as NHS receives more protective equipment
One of the projects will investigate potential vaccines, and could begin as early as June.
Five-year Zolgensma data shows SMA benefit
If left untreated, SMA type I leads to death or the need for permanent ventilation by the age of two in more than 90% of cases.
COVID-19: UK clinical tests to start next month as global authorities see spike in unauthorised meds
According to Interpol, the seizures represent “only the tip of the iceberg”, as surgical masks were also named as the counterfeit medical device most commonly sold online.
FDA dismisses Jardiance for type I diabetes
The decision follows an FDA panel vote last November recommending against the approval of the drug.
NHS enters major deal to expand hospital capacity, including 8,000 beds
The independent sector will also reallocate practically its entire national hospital capacity to the NHS.
ViiV sees first global approval of Cabenuva in Canada
Canada has also approved Vocabria to be used for short time periods in conjunction with the drug.
